Méndez-Sánchez N - Search Results

1

A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health.

Ramírez-Mejía MM, Díaz-Orozco LE, Barranco-Fragoso B, Méndez-Sánchez N. Ramírez-Mejía MM, et al. Med Sci Monit. 2021 Aug 30;27:e934134. doi: 10.12659/MSM.934134. Med Sci Monit. 2021. PMID: 34456329 Free PMC article. Review.

2

Metabolic syndrome as a risk factor for gallstone disease.

Méndez-Sánchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodríguez G, Baptista H, Ramos MH, Uribe M. Méndez-Sánchez N, et al. World J Gastroenterol. 2005 Mar 21;11(11):1653-7. doi: 10.3748/wjg.v11.i11.1653. World J Gastroenterol. 2005. PMID: 15786544 Free PMC article.

3

Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data.

Méndez-Sánchez N, Villa AR, Chávez-Tapia NC, Ponciano-Rodriguez G, Almeda-Valdés P, González D, Uribe M. Méndez-Sánchez N, et al. Ann Hepatol. 2005 Jan-Mar;4(1):52-5. Ann Hepatol. 2005. PMID: 15798662 Free article.

4

Adiponectin, structure, function and pathophysiological implications in non-alcoholic fatty liver disease.

Méndez-Sánchez N, Chavez-Tapia NC, Zamora-Valdés D, Uribe M. Méndez-Sánchez N, et al. Mini Rev Med Chem. 2006 Jun;6(6):651-6. doi: 10.2174/138955706777435689. Mini Rev Med Chem. 2006. PMID: 16787375 Review.

5

Current concepts in the pathogenesis of nonalcoholic fatty liver disease.

Méndez-Sánchez N, Arrese M, Zamora-Valdés D, Uribe M. Méndez-Sánchez N, et al. Liver Int. 2007 May;27(4):423-33. doi: 10.1111/j.1478-3231.2007.01483.x. Liver Int. 2007. PMID: 17403181 Review.

6

High ghrelin and obestatin levels and low risk of developing fatty liver.

Gutierrez-Grobe Y, Villalobos-Blasquez I, Sánchez-Lara K, Villa AR, Ponciano-Rodríguez G, Ramos MH, Chavez-Tapia NC, Uribe M, Méndez-Sánchez N. Gutierrez-Grobe Y, et al. Ann Hepatol. 2010 Jan-Mar;9(1):52-7. Ann Hepatol. 2010. PMID: 20308723 Free article.

7

In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry.

Roldan-Valadez E, Favila R, Martínez-López M, Uribe M, Ríos C, Méndez-Sánchez N. Roldan-Valadez E, et al. J Hepatol. 2010 Oct;53(4):732-7. doi: 10.1016/j.jhep.2010.04.018. Epub 2010 Jun 8. J Hepatol. 2010. PMID: 20594607

8

Prevalence of type 2 diabetes mellitus and chronic liver disease: a retrospective study of the association of two increasingly common diseases in Mexico.

Kobashi-Margáin RA, Gutiérrez-Grobe Y, Ponciano-Rodríguez G, Uribe M, Méndez-Sánchez N. Kobashi-Margáin RA, et al. Ann Hepatol. 2010 Jul-Sep;9(3):282-8. Ann Hepatol. 2010. PMID: 20720269 Free article.

9

Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens.

Gutierrez-Grobe Y, Ponciano-Rodríguez G, Ramos MH, Uribe M, Méndez-Sánchez N. Gutierrez-Grobe Y, et al. Ann Hepatol. 2010 Oct-Dec;9(4):402-9. Ann Hepatol. 2010. PMID: 21057159 Free article.

10

Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal states.

Méndez-Sánchez N, García-Villegas E, Merino-Zeferino B, Ochoa-Cruz S, Villa AR, Madrigal H, Kobashi-Margáin RA, Gutiérrez-Grobe Y, Chávez-Tapia N, Ponciano-Rodríguez G, Uribe M. Méndez-Sánchez N, et al. Ann Hepatol. 2010 Oct-Dec;9(4):428-38. Ann Hepatol. 2010. PMID: 21057162 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

377 results

Search Page